gefitinib has been researched along with shogaol in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (shogaol) | Trials (shogaol) | Recent Studies (post-2010) (shogaol) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 298 | 4 | 228 |
| Protein | Taxonomy | gefitinib (IC50) | shogaol (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 4 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 7.4 | |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 0.29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, TW; Lee, HG | 1 |
1 other study(ies) available for gefitinib and shogaol
| Article | Year |
|---|---|
6-Shogaol Overcomes Gefitinib Resistance via ER Stress in Ovarian Cancer Cells.
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Endoplasmic Reticulum Stress; Female; Gefitinib; Humans; Ovarian Neoplasms; Reactive Oxygen Species | 2023 |